These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5278389)

  • 21. Chemotherapy of disseminated malignant melanoma with imidazol carboxamide (DTIC) and cyclophosphamide. Preliminary results.
    Rudolf Z; Plesnicar S
    Anticancer Res; 1982; 2(1-2):37-9. PubMed ID: 7051959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and cyclophosphamide in osteosarcoma survivors.
    Kharasch VS; Lipsitz S; Santis W; Hallowell JA; Goorin A
    Med Pediatr Oncol; 1996 Aug; 27(2):85-91. PubMed ID: 8649325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preoperative adjuvant therapy for primary malignant bone tumors].
    Goto T; Okuma T; Nakada I; Hozumi T; Kondo T
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1750-4. PubMed ID: 18030009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of metastases of breast cancer by an immediate combination of hormonal treatment and chemotherapy with nonhormonal cytostatics].
    Mannes P; Derriks R
    Acta Tuberc Pneumol Belg; 1968; 59(2):445-54. PubMed ID: 5720490
    [No Abstract]   [Full Text] [Related]  

  • 25. [Preliminary findings of the chemotherapeutic metastasis prophylaxis in osteosarcoma].
    Salzer M
    Krebsarzt; 1968; 23(4):251-5. PubMed ID: 5248183
    [No Abstract]   [Full Text] [Related]  

  • 26. [The role of polychemotherapy in the management of malignant bone tumors].
    Reichardt P; Dörken B
    Chirurg; 2002 Dec; 73(12):1170-3. PubMed ID: 12491045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of delayed-action high-dosage parenteral 6-methyl-prednisolone in oncology].
    Rizzo SC
    Minerva Med; 1974 Mar; 65(20):1078-81. PubMed ID: 4524324
    [No Abstract]   [Full Text] [Related]  

  • 28. A bioluminescent orthotopic mouse model of human osteosarcoma that allows sensitive and rapid evaluation of new therapeutic agents In vivo.
    Comstock KE; Hall CL; Daignault S; Mandlebaum SA; Yu C; Keller ET
    In Vivo; 2009; 23(5):661-8. PubMed ID: 19779098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hormonal treatment with non-virilizing androgens, in a case of extensive bone metastasis of an epithelioma of the breast].
    Tardiveau J; Philippon J
    J Radiol Electrol Med Nucl; 1970 Dec; 51(12):801-2. PubMed ID: 5510215
    [No Abstract]   [Full Text] [Related]  

  • 30. Selected applications of methotrexate alone and in combination in osteosarcoma.
    Pratt CB
    Cancer Treat Rep; 1981; 65 Suppl 1():107-11. PubMed ID: 6976828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical evaluation on the sensitivity test for anti-cancer agents in malignant bone and soft-tissue tumors].
    Takeuchi S; Akahoshi Y; Kasai C; Nishimoto Y
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1113-22. PubMed ID: 6088833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Urinary pyrophosphate and hydroxyproline in bone tumors].
    Maeda H
    Nihon Seikeigeka Gakkai Zasshi; 1969 Dec; 43(11):1075-85. PubMed ID: 4314548
    [No Abstract]   [Full Text] [Related]  

  • 33. [Chemotherapy of lung cancer].
    Oka S
    Gan No Rinsho; 1968 Jan; 14(1):56-8. PubMed ID: 5692164
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment results in osteogenic sarcoma in children and adolescents with the use of karminomycin].
    Bizer VA; Timukhina VN
    Antibiotiki; 1984 Jan; 29(1):56-9. PubMed ID: 6582798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Periosteal osteosarcoma--a European review of outcome.
    Grimer RJ; Bielack S; Flege S; Cannon SR; Foleras G; Andreeff I; Sokolov T; Taminiau A; Dominkus M; San-Julian M; Kollender Y; Gosheger G;
    Eur J Cancer; 2005 Dec; 41(18):2806-11. PubMed ID: 16290134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Disorders of blood rheology in Walker's carcinosarcoma-256 and in cyclophosphamide treatment of rats].
    Plotnikov MB; Maslov MIu; Aliev OI; Vasil'ev AS; Zueva EP; Krylova SG; Shilova NV
    Vopr Onkol; 2001; 47(3):335-7. PubMed ID: 11544834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Regional intra-arterial chemotherapy of bone tumors].
    Pozdnuchov LG; Balmuchov SB; Voronkina NG; Kabiov OK
    Acta Chir Orthop Traumatol Cech; 1966 Jun; 33(3):214-7. PubMed ID: 5228114
    [No Abstract]   [Full Text] [Related]  

  • 38. [Modern views on the treatment of osteogenic sarcoma].
    Górecki A; Dulowski W; Małdyk P; Adamkiewicz T
    Wiad Lek; 1982 Jun; 35(6):426-32. PubMed ID: 6957070
    [No Abstract]   [Full Text] [Related]  

  • 39. [Shock doses of endoxan in the therapy of malignant lung neoplasms (based on personal observations)].
    Ratajek M
    Wiad Lek; 1970 Jan; 23(1):15-8. PubMed ID: 5412426
    [No Abstract]   [Full Text] [Related]  

  • 40. [Conservative treatment of primary malignant bone tumors in children. Review of 14 cases].
    Ben Hamida H; Boussen H; Safi H; Khattech R; Ben Romdhane K; Hammou A; Ben Ayed F; Ben Ghachem M
    Tunis Med; 1996 Oct; 74(10):425-31. PubMed ID: 9506103
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.